Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 14, 2019

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.

Latest News

Ampio Provides Update on COVID-19 Program

May 22, 2020

Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion™ for COVID-19 Patients

May 11, 2020

Ampio Pharmaceutical’s Application to the FDA for a Clinical Study of Ampion to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)

April 2, 2020
member-logo-85

© 2020 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Clinical Trial
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us